A Phase 1 study of VX-445 to evaluate single ascending doses, multiple ascending doses and triple combination dosing with the tezacaftor/ivacaftor combination in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 03 May 2017
At a glance
- Drugs VX 445 (Primary) ; Ivacaftor/tezacaftor
- Indications Cystic fibrosis
- Focus Adverse reactions; Pharmacokinetics
- 03 May 2017 New trial record